Key Events This Week
18 May: Stock opens at Rs.2,302.55, down 2.70%
21 May: New 52-week and all-time high at Rs.2,560
22 May: Hits record high of Rs.2,619.95
22 May: Week closes at Rs.2,528.85, up 6.86%

Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2619.95
2026-05-22 09:47:36Surging past its previous peaks, Fredun Pharmaceuticals Ltd reached a new 52-week high of Rs 2619.95 on 22 May 2026, marking a remarkable rally that has seen the stock gain over 250% in the past year. This milestone reflects a powerful confluence of technical momentum and sustained price strength, setting the stage for further market attention.
Read full news article
Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 2,619.95 as Momentum Builds Across Timeframes
2026-05-22 09:33:51Extending its winning streak to four consecutive sessions, Fredun Pharmaceuticals Ltd surged to a fresh all-time high of Rs 2,619.95 on 22 May 2026, outperforming its sector and the broader market with a 1.81% gain on the day against the Sensex’s 0.46% rise.
Read full news article
Broad-Based Technical Strength Lifts Fredun Pharmaceuticals Ltd to 52-Week High of Rs 2560
2026-05-21 15:10:48Surging past its previous peaks, Fredun Pharmaceuticals Ltd reached a fresh 52-week high of Rs 2560 on 21 May 2026, marking a remarkable rally from its 52-week low of Rs 690. This milestone caps a sustained upward momentum driven by a confluence of robust technical indicators and strong price action over recent sessions.
Read full news article
Fredun Pharmaceuticals Ltd is Rated Buy
2026-05-17 10:10:37Fredun Pharmaceuticals Ltd is rated Buy by MarketsMOJO, with this rating last updated on 13 Apr 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 17 May 2026, providing investors with the latest insights into its performance and outlook.
Read full news article








